These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33249200)

  • 41. Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure Registry.
    Schrage B; Uijl A; Benson L; Westermann D; Ståhlberg M; Stolfo D; Dahlström U; Linde C; Braunschweig F; Savarese G
    Circulation; 2019 Nov; 140(19):1530-1539. PubMed ID: 31476893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
    Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implantable Cardioverter-Defibrillator Placement for Primary Prevention in 2,346 Patients: Predictors of One-Year Survival.
    Merchant FM; Desai Y; Addish MA; Kelly K; Casey M; Goyal A; Leon AR; El-Chami MF
    Tex Heart Inst J; 2018 Aug; 45(4):221-225. PubMed ID: 30374229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Favorable Trend of Implantable Cardioverter-Defibrillator Service Life in a Large Single-Nation Population: Insights From 10-Year Analysis of the Italian Implantable Cardioverter-Defibrillator Registry.
    Poli S; Boriani G; Zecchin M; Facchin D; Gasparini M; Landolina M; Ricci RP; Lanera C; Gregori D; Proclemer A
    J Am Heart Assoc; 2019 Aug; 8(15):e012759. PubMed ID: 31340695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implantable cardioverter defibrillator therapy in young patients with cardiomyopathies and channelopathies: a single Italian centre experience.
    Migliore F; Silvano M; Zorzi A; Bertaglia E; Siciliano M; Leoni L; De Franceschi P; Iliceto S; Corrado D
    J Cardiovasc Med (Hagerstown); 2016 Jul; 17(7):485-93. PubMed ID: 27136702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term outcome of implantable cardioverter-defibrillator implantation in secondary prevention of sudden cardiac death.
    Boulé S; Sémichon M; Guédon-Moreau L; Drumez É; Kouakam C; Marquié C; Brigadeau F; Kacet S; Potelle C; Escande W; Souissi Z; Lacroix D; Duhamel A; Klug D
    Arch Cardiovasc Dis; 2016 Oct; 109(10):517-526. PubMed ID: 27342808
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardioverter-defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction.
    Jilek C; Lewalter T; Pauschinger M; von Scheidt W; Frankenstein L; Pfister O; Hambrecht R; Bruder O; Brachmann J; Hartmann A; Strasser R; Hochadel M; Senges J
    Clin Res Cardiol; 2020 Jan; 109(1):115-123. PubMed ID: 31236690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reassessment of clinical variables in cardiac resynchronization defibrillator patients at the time of first replacement: Death after replacement of CRT (DARC) score.
    Theuns DAMJ; Niazi K; Schaer BA; Sticherling C; Yap SC; Caliskan K
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1687-1694. PubMed ID: 33825257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of remote monitoring on long-term cardiovascular outcomes after cardioverter-defibrillator implantation.
    Portugal G; Cunha P; Valente B; Feliciano J; Lousinha A; Alves S; Braz M; Pimenta R; Delgado AS; Oliveira M; Ferreira RC
    Int J Cardiol; 2016 Nov; 222():764-768. PubMed ID: 27521554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Impact of Implantable Cardioverter-Defibrillator Therapy and Mortality Prediction Model for Effective Primary Prevention in Korean Patients.
    Bae MH; Cho Y; Hwang J; Park HS; Han S; Lee YS; Cho HJ; Jung BC; Lee CH; Hyun DW; Park JS; Ahn J; Kim KH; Shin DG
    J Korean Med Sci; 2020 Mar; 35(9):e49. PubMed ID: 32141247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Device Histogram-Based Simple Predictor of Mortality Risk in ICD and CRT-D Patients: The Heart Rate Score.
    Wilkoff BL; Richards M; Sharma A; Wold N; Jones P; Perschbacher D; Olshansky B
    Pacing Clin Electrophysiol; 2017 Apr; 40(4):333-343. PubMed ID: 28156008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
    Chen TB; Cheng KA; Gao P; Cheng ZW; Fan JB; Jiang XC; Fang Q
    Chin Med J (Engl); 2010 Apr; 123(7):848-51. PubMed ID: 20497676
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting defibrillator benefit in patients with cardiac resynchronization therapy: A competing risk study.
    Weber D; Koller M; Theuns D; Yap S; Kühne M; Sticherling C; Reichlin T; Szili-Torok T; Osswald S; Schaer B
    Heart Rhythm; 2019 Jul; 16(7):1057-1064. PubMed ID: 30710738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-Term Survival With Implantable Cardioverter-Defibrillator in Different Symptomatic Functional Classes of Heart Failure.
    Biton Y; Rosero S; Moss A; Zareba W; Kutyifa V; Baman J; Barsheshet A; McNitt S; Polonsky B; Goldenberg I
    Am J Cardiol; 2018 Mar; 121(5):615-620. PubMed ID: 29307459
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.
    Biton Y; Moss AJ; Kutyifa V; Mathias A; Sherazi S; Zareba W; McNitt S; Polonsky B; Barsheshet A; Brown MW; Goldenberg I
    Circ Heart Fail; 2015 Sep; 8(5):921-6. PubMed ID: 26179186
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequency, predictors and prognostic impact of implantable cardioverter defibrillator shocks in a primary prevention population with heart failure and reduced ejection fraction.
    Masini M; Elia E; Vianello PF; Bertero G; Rossi P; Ameri P; Chiarella F; Brunelli C; Porto I; Sartori P; Canepa M
    J Cardiovasc Med (Hagerstown); 2021 Feb; 22(2):118-125. PubMed ID: 32941323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.
    Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO
    Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term follow-up of patients with chronic chagas disease and implantable cardioverter-defibrillator.
    Pereira FT; Rocha EA; Monteiro Mde P; Neto AC; Daher Ede F; Sobrinho CR; Pires Neto Rda J
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):751-6. PubMed ID: 24467488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early mortality after implantable cardioverter defibrillator: Incidence and associated factors.
    Garcia R; Boveda S; Defaye P; Sadoul N; Narayanan K; Perier MC; Klug D; Fauchier L; Leclercq C; Babuty D; Bordachar P; Gras D; Deharo JC; Piot O; Providencia R; Marijon E; Algalarrondo V;
    Int J Cardiol; 2020 Feb; 301():114-118. PubMed ID: 31753583
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health status measured by Kansas City Cardiomyopathy Questionnaire-12 in primary prevention implantable cardioverter defibrillator patients with heart failure.
    Mattsson G; Wallhagen M; Magnusson P
    BMC Cardiovasc Disord; 2021 Aug; 21(1):411. PubMed ID: 34454427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.